160 related articles for article (PubMed ID: 23557209)
1. Radiosynthesis and preclinical evaluation of [11C]prucalopride as a potential agonist PET ligand for the 5-HT4 receptor.
Buiter HJ; Windhorst AD; Huisman MC; De Maeyer JH; Schuurkes JA; Lammertsma AA; Leysen JE
EJNMMI Res; 2013 Apr; 3(1):24. PubMed ID: 23557209
[TBL] [Abstract][Full Text] [Related]
2. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L
Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162
[TBL] [Abstract][Full Text] [Related]
3. Prucalopride exerts neuroprotection in human enteric neurons.
Bianco F; Bonora E; Natarajan D; Vargiolu M; Thapar N; Torresan F; Giancola F; Boschetti E; Volta U; Bazzoli F; Mazzoni M; Seri M; Clavenzani P; Stanghellini V; Sternini C; De Giorgio R
Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(10):G768-75. PubMed ID: 26893157
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and preclinical evaluation of [11C]D617, a metabolite of (R)-[11C]verapamil.
Verbeek J; Syvänen S; Schuit RC; Eriksson J; de Lange EC; Windhorst AD; Luurtsema G; Lammertsma AA
Nucl Med Biol; 2012 May; 39(4):530-9. PubMed ID: 22226023
[TBL] [Abstract][Full Text] [Related]
5. Prucalopride is a partial agonist through human and porcine atrial 5-HT4 receptors: comparison with recombinant human 5-HT4 splice variants.
Krobert KA; Brattelid T; Levy FO; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):473-9. PubMed ID: 16012870
[TBL] [Abstract][Full Text] [Related]
6. Nonclinical Cardiovascular Studies of Prucalopride, a Highly Selective 5-Hydroxytryptamine 4 Receptor Agonist.
Conlon K; De Maeyer JH; Bruce C; Schuurkes JAJ; Christie L; McRedmond J; Derakhchan K; Wade PR
J Pharmacol Exp Ther; 2018 Feb; 364(2):156-169. PubMed ID: 29180358
[TBL] [Abstract][Full Text] [Related]
7. Radiosynthesis and ex vivo evaluation of [11C]-SIB-1553A as a PET radiotracer for beta4 selective subtype nicotinic acetylcholine receptor.
Sobrio F; Quentin T; Dhilly M; Bourdier T; Tymciu S; Debruyne D; Barré L
Nucl Med Biol; 2008 Apr; 35(3):377-85. PubMed ID: 18355694
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of prucalopride in adults and children with chronic constipation.
Diederen K; Mugie SM; Benninga MA
Expert Opin Pharmacother; 2015 Feb; 16(3):407-16. PubMed ID: 25539475
[TBL] [Abstract][Full Text] [Related]
9. A PET Tracer for Brain α2C Adrenoceptors, (11)C-ORM-13070: Radiosynthesis and Preclinical Evaluation in Rats and Knockout Mice.
Arponen E; Helin S; Marjamäki P; Grönroos T; Holm P; Löyttyniemi E; Någren K; Scheinin M; Haaparanta-Solin M; Sallinen J; Solin O
J Nucl Med; 2014 Jul; 55(7):1171-7. PubMed ID: 24799619
[TBL] [Abstract][Full Text] [Related]
10. Intraluminal prucalopride increases propulsive motor activities via luminal 5-HT
Shokrollahi M; Chen JH; Huizinga JD
Neurogastroenterol Motil; 2019 Oct; 31(10):e13598. PubMed ID: 31012538
[TBL] [Abstract][Full Text] [Related]
11. Synergy between 5-HT4 receptor activation and acetylcholinesterase inhibition in human colon and rat forestomach.
Cellek S; Thangiah R; Jarvie EM; Vivekanandan S; Lalude O; Sanger GJ
Neurogastroenterol Motil; 2008 May; 20(5):539-45. PubMed ID: 18194150
[TBL] [Abstract][Full Text] [Related]
12. The 5-HT4 Receptor Agonist Prucalopride Stimulates Mucosal Growth and Enhances Carbohydrate Absorption in the Ileum of the Mouse.
Park CJ; Armenia SJ; Zhang L; Cowles RA
J Gastrointest Surg; 2019 Jun; 23(6):1198-1205. PubMed ID: 30109470
[TBL] [Abstract][Full Text] [Related]
13. [11C]phenytoin revisited: synthesis by [11C]CO carbonylation and first evaluation as a P-gp tracer in rats.
Verbeek J; Eriksson J; Syvänen S; Labots M; de Lange EC; Voskuyl RA; Mooijer MP; Rongen M; Lammertsma AA; Windhorst AD
EJNMMI Res; 2012 Jul; 2(1):36. PubMed ID: 22747744
[TBL] [Abstract][Full Text] [Related]
14. [11C]AF150(S), an agonist PET ligand for M1 muscarinic acetylcholine receptors.
Buiter HJ; Windhorst AD; Huisman MC; Yaqub M; Knol DL; Fisher A; Lammertsma AA; Leysen JE
EJNMMI Res; 2013 Mar; 3(1):19. PubMed ID: 23514539
[TBL] [Abstract][Full Text] [Related]
15. Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation.
Shin A; Camilleri M; Kolar G; Erwin P; West CP; Murad MH
Aliment Pharmacol Ther; 2014 Feb; 39(3):239-53. PubMed ID: 24308797
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vivo evaluation of a novel peripheral benzodiazepine receptor PET radioligand.
James ML; Fulton RR; Henderson DJ; Eberl S; Meikle SR; Thomson S; Allan RD; Dolle F; Fulham MJ; Kassiou M
Bioorg Med Chem; 2005 Nov; 13(22):6188-94. PubMed ID: 16039131
[TBL] [Abstract][Full Text] [Related]
17. Studies on the metabolism of the novel antitumor agent [N-methyl-11C]N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in rats and humans prior to phase I clinical trials.
Osman S; Luthra SK; Brady F; Hume SP; Brown G; Harte RJ; Matthews JC; Denny WA; Baguley BC; Jones T; Price PM
Cancer Res; 1997 Jun; 57(11):2172-80. PubMed ID: 9187117
[TBL] [Abstract][Full Text] [Related]
18. The 5-HT
Lefebvre RA; Callens C; Van Colen I; Delesalle CJG
Res Vet Sci; 2017 Oct; 114():153-162. PubMed ID: 28419939
[TBL] [Abstract][Full Text] [Related]
19. Radiosynthesis, ex vivo and in vivo evaluation of [11C]preclamol as a partial dopamine D2 agonist radioligand for positron emission tomography.
Vasdev N; Natesan S; Galineau L; Garcia A; Stableford WT; McCormick P; Seeman P; Houle S; Wilson AA
Synapse; 2006 Sep; 60(4):314-8. PubMed ID: 16786538
[TBL] [Abstract][Full Text] [Related]
20. The 5-hydroxytryptamine4 receptor agonists prucalopride and PRX-03140 increase acetylcholine and histamine levels in the rat prefrontal cortex and the power of stimulated hippocampal θ oscillations.
Johnson DE; Drummond E; Grimwood S; Sawant-Basak A; Miller E; Tseng E; McDowell LL; Vanase-Frawley MA; Fisher KE; Rubitski DM; Stutzman-Engwall KJ; Nelson RT; Horner WE; Gorczyca RR; Hajos M; Siok CJ
J Pharmacol Exp Ther; 2012 Jun; 341(3):681-91. PubMed ID: 22408061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
